Hextar Healthcare Bhd

Hextar Healthcare Bhd's next confirmed earnings release is scheduled for November 26, 2026.

As of June 30, 2026, Hextar Healthcare Bhd has 1.10B shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.50, and the price-to-book ratio stands at 0.15.

These figures are as of June 30, 2026. The EV/Sales ratio of 0.32 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Hextar Healthcare Bhd trades at an EV/FCF ratio of 5.87, comparing the total takeover cost of the business to the cash it actually generates for all capital providers.

As of June 30, 2026, Hextar Healthcare Bhd maintains a current ratio of 4.34, meaning it holds 4.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.75, indicating moderate leverage, while an interest coverage ratio of -137.02 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Hextar Healthcare Bhd posted a negative return on equity (ROE) of -10.74, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -10.01, reflecting losses generated across the asset base. Inventory turnover of 2.59 indicates how many times Hextar Healthcare Bhd sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 23, 2026, Hextar Healthcare Bhd's stock has declined approximately 47.62% over the past 52 weeks. The 50-day moving average sits at 0.06, while the 200-day moving average is 0.07.

Over the twelve months ended June 30, 2026, Hextar Healthcare Bhd posted a gross margin of -7.50, reflecting its pricing power and cost economics. The operating margin of -17.88 and net profit margin of -37.47 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 10.51, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 1.47, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Hextar Healthcare Bhd shareholders.

Hextar Healthcare Bhd's most recent stock split took place on October 19, 2020 with a 1:3 split ratio.

As of June 30, 2026, Hextar Healthcare Bhd has an Altman Z-Score of 2.15, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.